Showing Form 4 filings for TARS
Pre-configured institutional-grade criteria for instant high-conviction screening
Multiple insiders buying stock within the last 30 days
Direct open-market purchases by Chief Executive Officers
Financial chiefs and top corporate officers accumulating shares
Institutional-scale insider purchases of $1,000,000 or greater
Insiders increasing their overall equity ownership by over 20%
High-value executive divestments by CEOs and CFOs over $1M
TARS
Price
$90.56
Shares
10,000
Ownership
861,412
Value/Share
Azamian Bobak R.
Pres, CEO, Board Chair
Unknown
Industry
$87.50
13,953
16,177
Lin Elizabeth Yeu
Chief Medical Officer
$85.00
4,564
79,007
Neervannan Seshadri
COO
$80.06
871,412
$61.55
881,412
$62.08
2,954
2,233
Goodrich Katherine
Dir
$62.12
12,500
106,786
Link William J Phd
$66.75
2,989
83,266
$68.36
12,274
35,028
Whitfield Dianne C.
CHRO
12,440
63,959
Wahl Bryan
GC
$68.21
11,324
86,255
13,056
61,480
Mottiwala Aziz
Chief Commercial Officer
1,144
41,708
6,430
43,316
Farrow Jeffrey S
See Remarks
$68.34
34,603
891,412
$68.79
116,332
$76.67
8,366
71,292
$80.67
15,565
23,393
$82.51
6,000
859,741
$80.10
7,397
38,958
$81.26
22,946
128,832
$55.37
865,741
$57.00
27,116
153,778
$50.00
871,741
$43.76
17,500
47,557
877,741
$47.88
10,565
65,057
$47.89
7,583
79,682
9,686
51,712
6,711
46,355
$48.03
24,216
883,741
3,724
22,431